<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05088512</url>
  </required_header>
  <id_info>
    <org_study_id>1207</org_study_id>
    <nct_id>NCT05088512</nct_id>
  </id_info>
  <brief_title>The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population</brief_title>
  <official_title>Preventive and Personalized Medicine (2021-2023)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asfendiyarov Kazakh National Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asfendiyarov Kazakh National Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To research for a genetic marker of bronchial asthma, a single nucleotide polymorphism (SNP)&#xD;
      analysis of DNA obtained from the peripheral blood of patients with bronchial asthma and&#xD;
      normal control will be performed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unrelated Kazaks subjects who have bronchial asthma were recruited in the current study.&#xD;
      Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be&#xD;
      performed. Genotypes would be statistically compared between patients with bronchial asthma&#xD;
      and normal control subjects free of bronchial asthma&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 23, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of SNPs associated with bronchial asthma</measure>
    <time_frame>1 year</time_frame>
    <description>Using SNPsto identify candidate genes associate with bronchial asthma</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bronchial Asthma</condition>
  <condition>Genome Wide Association Studies</condition>
  <arm_group>
    <arm_group_label>Experimental group:</arm_group_label>
    <description>Patients with bronchial asthma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients without bronchial asthma</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>SNP analysis of the DNA</intervention_name>
    <description>SNP analysis of the DNA obtained from peripheral blood sample</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group:</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Persons with bronchial asthma confirmed by a doctor&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Persons with bronchial asthma confirmed by a doctor;&#xD;
&#xD;
          -  The age of the patients is from 5 to 60 years;&#xD;
&#xD;
          -  Persons of Kazakh nationality, whose paternal and maternal grandparents are Kazakhs.&#xD;
&#xD;
          -  Persons who are able and willing to provide written informed consent;&#xD;
&#xD;
          -  Persons capable and willing to comply with the research protocol;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Persons who, in the opinion of the researcher, are mentally or legally incapacitated,&#xD;
             which prevents obtaining informed consent;&#xD;
&#xD;
          -  Pregnant or lactating women;&#xD;
&#xD;
          -  Tuberculosis of any localization in the active phase and in history;&#xD;
&#xD;
          -  Severe and decompensated diseases of the liver and kidneys, cardiovascular system;&#xD;
&#xD;
          -  Severe and decompensated course of endocrine diseases;&#xD;
&#xD;
          -  Autoimmune diseases;&#xD;
&#xD;
          -  Systemic diseases;&#xD;
&#xD;
          -  Oncological diseases;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhanat B. Ispayeva, PhD</last_name>
    <phone>+77772773847</phone>
    <email>ispayeva.zh@kaznmu.kz</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kazakhstan</name>
      <address>
        <city>Almaty</city>
        <zip>050020</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <contact>
      <last_name>Zhanat B Ispaeva, PhD</last_name>
      <phone>+77772773847</phone>
      <email>ispayeva.zh@kaznmu.kz</email>
    </contact>
    <investigator>
      <last_name>Zhanat B Ispaeva, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Kazakhstan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 25, 2021</study_first_submitted>
  <study_first_submitted_qc>October 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asfendiyarov Kazakh National Medical University</investigator_affiliation>
    <investigator_full_name>Ildar Fakhradiyev</investigator_full_name>
    <investigator_title>Project manager</investigator_title>
  </responsible_party>
  <keyword>Bronchial Asthma</keyword>
  <keyword>Genome Wide Association Studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

